Latest Biotechnology, Pharmaceutical and Healthcare News

13:22 EST 18th December 2014 | BioPortfolio

Showing News Articles 1–25 of 730,000+

Thursday 18th December 2014

Lannett Receives FDA Approval for Dorzolamide HCL with Timolol

Lannett Company, Inc. (NYSE: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, 2%/0.5%, the therapeutic equivalent to the reference listed drug, Cosopt® Ophthalmic Solution, 2%/0.5%, of Oak...

FUJIFILM Completes Acquisition of Kalon Biotherapeutics

Acquisition Enhances Texas’ Growing Reputation as a Global Biotechnology Leader FUJIFILM Diosynth Biotechnologies U.S.A. Inc. (FDBU), a FUJIFILM Corporation subsidiary, today announced the

Dr. Tanya Mayadas Joins Biothera's Research Advisory Board

Biothera announced today that Tanya Mayadas, Ph.D. has joined its Research Advisory Board. Dr. Mayadas is a Professor of Pathology at Harvard Medical School, Boston, MA. She has a broad background in inflammation, with specific expertise in elucidating the neutrophil-dependent mechanisms of tissue injury in disease. Over the past 20 years, Dr. May...

GSK's shingles vaccine threatens Merck/Sanofi's Zostavax

GSK said that a filing on the back of these data is "definitely a possibility", but that the decision had not yet been taken. Full data are expected to be published early next year.

Lymphoma Research Foundation Partners with Neiman Marcus Boca Raton in the Fight Against Blood Cancer During Annual Fashion Luncheon

Lymphoma Research Foundation Luncheon Returns to South Florida for Ninth Year Boca Raton, FL (PRWEB) December 18, 2014 The South Florida community is poised once again to show its support for the Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensiv...

Speedy EU approval for AZ's key new anticancer Lynparza

ForeverGreen Worldwide Corporation Accelerates Business in Japan

CEO and other senior management travel to Japan to enhance business in region Pleasant Grove, Utah (PRWEB) December 18, 2014 ForeverGreen Worldwide Corporation (OTCBB: FVRG), a leading direct marketing company and provider of health-centered products, today announced Ron Williams, CEO and founder of ForeverGreen, as well as several other senior executives traveled to Japan to meet with top leader...

Clay Matthews of the Green Bay Packers Featured in New Cure Duchenne PSA To Help the Fight to Find a Cure for Duchenne Muscular Dystrophy

CureDuchenne announced today that Clay Matthews of the

Roche to pay up to $489 mln for next generation antibody firm

Dec 18 (Reuters) - Switzerland's Roche said on Thursday it had agreed to pay up to $489 million to acquire Austrian biotech company Dutalys, a specialist in the discovery and development of so-called bi-specific antibodies.

Flu season has now ‘started’, warn public health officials

Latest figures from Public Health England indicate that influenza is now circulating in the community.

Heart experts warn of air pollution dangers

(Reuters Health) - Air pollution should be one of the avoidable heart risk factors - just like smoking and excess fat - that doctors warn patients to steer clear of, according to a new statement from 20 heart experts.

EU court ruling removes another obstacle to stem cell patenting

Tetraphase's antibiotic 'as good as Merck's' in Phase III

Tetraphase Pharmaceuticals' share price soared on news that eravacycline, its novel antibiotic to treat complicated intra-abdominal infections, was as effective as Merck & Co's ertapenem in the Phase III IGNITE 1 study. Its shares closed more than 10...

CORRECTED-Colorado awards $8 million to study medical marijuana uses

(Corrects paragraph 7 in Dec. 17 story to clarify that funding comes from patient registration fees, not taxes on medical marijuana sales)

Pancreatic grafts made immune-tolerant

Stem cell-derived tissue reverses diabetes in humanized mice; ViaCyte helps study.

Cellectis Plant Sciences and Two Blades Foundation Announce the Execution of a Cross-License Agreement on TAL Effector Nuclease Technologies

Regulatory News: Cellectis (Paris:ALCLS): Cellectis plant sciences, a Minnesota-based company focusing on developing healthier food products, and the Two Blades Foundation (2Blades) today announced the execution of a non-exclusive cross-license agreement relating to TAL nuclease technologies. Pursuant to the agreement, 2Bl...

OptiNose to Present at the 33rd Annual J.P. Morgan Healthcare Conference

OptiNose today announced that the company will present at the 33rd annual J.P. Morgan Healthcare Conference. CEO Peter Miller will discuss the Company's recent milestones, pipeline and strategy for 2015. “Our bi-directional Breath Powered technology has the potential to improve treatment for patients across a wide range of underserved disease st...

Ella Marie Foundation Launches New Website

The Ella Marie Foundation, a nonprofit organization dedicated to making a difference in the lives of women and children across the globe, today unveiled a new website, www.ellamariefoundation.org. The Ella Marie Foundation focuses on attacking the triple threat of hunger, health and ignorance to help women and children reach their

NICE issues priorities for treating sick babies with antibiotics

The National Institute for Health and Care Excellence has issued a new quality standard setting out priorities on the use of antibiotics to prevent and treat infections in newborn babies.

BRIEF-Evotec reaches milestones triggering 8 mln eur of revenue

* Achievement of multiple milestones in Evotec's drug discovery alliances

CSL Behring files BLA for hemophilia B agent

USA-based CSL Behring, a unit of Australia’s CSL Ltd, has submitted a biologics license application (BLA) to the US Food and Drug Administration for the marketing authorization of its long-acting fusion protein linking recombinant coagulation facto...

IMS Institute Identifies Innovative Payment Models for Pharmaceuticals at Forbes Healthcare Summit

Advances Discussion on How Big Data Can Drive Understanding of Patient Treatment, Costs and Outcomes New approaches for determining how much drugs should cost, and for setting the price for innovative treatments, were highlighted in a keynote presentation by Murray Aitken, IMS Health senior vice president and executive director of the IMS Institute for...

GSK shingles vaccine candidate meets Ph III primary endpoint

UK pharma major GlaxoSmithKline today released pivotal Phase III study data to assess the efficacy of HZ/su, an investigational vaccine for the prevention of shingles (post-herpetic neuralgia, or herpes zoster), noting that it has met its primary end...

FDA sends Pozen a second Complete Response Letter regarding Yosprala manufacturing issues

US pharma company Pozen has received a second complete response letter from the US Food and Drug Administration for Yosprala (aspirin/omeprazole delayed release tablets).

India's trial regulations choking academic research

''It's impossible for any academic researcher to do research in the current environment,'' is how Dr Pramesh, associate professor and head of thoracic surgery at the prestigious Tata Memorial Hospital in Mumbai, summed up the pain of academia grappli...


Search BioPortfolio:
Loading
Advertisement
Advertisement

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.